Clinical Trial: Budesonide Treatment for Lymphocytic Colitis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Efficacy and Safety of Budesonide for Treatment of Lymphocytic Colitis

Brief Summary: The purpose of this study is to determine whether orale budesonide is effective in the treatment of lymphocytic colitis

Detailed Summary: The purpose of this study is to determine whether orale budesonide is effective in the treatment of lymphocytic colitis
Sponsor: Technische Universität Dresden

Current Primary Outcome: Proportion of patients in clinical remission after 6 weeks

Original Primary Outcome: Same as current

Current Secondary Outcome:

  • safety
  • quality of life
  • histological improvement


Original Secondary Outcome: Same as current

Information By: Technische Universität Dresden

Dates:
Date Received: September 9, 2005
Date Started: January 2002
Date Completion:
Last Updated: March 29, 2010
Last Verified: March 2010